Performant Healthcare Return on Tangible Equity 2011-2024 | PHLT
Current and historical return on tangible equity values for Performant Healthcare (PHLT) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Performant Healthcare Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2024-12-31 | $-0.01B | $0.03B | -31.30% |
| 2024-09-30 | $-0.01B | $0.03B | -26.89% |
| 2024-06-30 | $-0.01B | $0.03B | -22.95% |
| 2024-03-31 | $-0.01B | $0.03B | -25.60% |
| 2023-12-31 | $-0.01B | $0.03B | -24.81% |
| 2023-09-30 | $-0.01B | $0.03B | -27.07% |
| 2023-06-30 | $-0.01B | $0.03B | -25.90% |
| 2023-03-31 | $-0.01B | $0.03B | -22.07% |
| 2022-12-31 | $-0.01B | $0.04B | -16.00% |
| 2022-09-30 | $-0.01B | $0.04B | -24.32% |
| 2022-06-30 | $-0.01B | $0.04B | -27.03% |
| 2022-03-31 | $-0.01B | $0.04B | -33.96% |
| 2021-12-31 | $-0.01B | $0.04B | -77.19% |
| 2021-09-30 | $0.00B | $0.04B | -100.00% |
| 2021-06-30 | $0.00B | $-0.01B | 0.00% |
| 2021-03-31 | $-0.01B | $-0.01B | 51.28% |
| 2020-12-31 | $-0.01B | $-0.01B | 120.93% |
| 2020-09-30 | $-0.02B | $-0.01B | 142.37% |
| 2020-06-30 | $-0.03B | $-0.01B | 165.33% |
| 2020-03-31 | $-0.03B | $-0.01B | 148.15% |
| 2019-12-31 | $-0.03B | $-0.02B | 128.40% |
| 2019-09-30 | $-0.03B | $-0.03B | 166.15% |
| 2019-06-30 | $-0.03B | $-0.02B | 251.16% |
| 2019-03-31 | $-0.03B | $-0.01B | 416.67% |
| 2018-12-31 | $-0.01B | $-0.01B | 514.29% |
| 2018-09-30 | $0.00B | $0.00B | 171.43% |
| 2018-06-30 | $0.00B | $0.00B | 109.09% |
| 2018-03-31 | $0.00B | $0.00B | 26.67% |
| 2017-12-31 | $-0.01B | $-0.01B | 218.18% |
| 2017-09-30 | $-0.03B | $-0.01B | 555.56% |
| 2017-06-30 | $-0.02B | $0.00B | 423.53% |
| 2017-03-31 | $-0.02B | $0.00B | 272.73% |
| 2016-12-31 | $-0.01B | $0.00B | 160.00% |
| 2016-09-30 | $0.00B | $-0.01B | -19.05% |
| 2016-06-30 | $0.00B | $-0.01B | -22.64% |
| 2016-03-31 | $0.00B | $-0.01B | -18.75% |
| 2015-12-31 | $0.00B | $-0.01B | 5.33% |
| 2015-09-30 | $-0.01B | $-0.02B | 24.69% |
| 2015-06-30 | $-0.01B | $-0.02B | 24.39% |
| 2015-03-31 | $0.00B | $-0.02B | 0.00% |
| 2014-12-31 | $0.01B | $-0.02B | -43.01% |
| 2014-09-30 | $0.02B | $-0.02B | -70.80% |
| 2014-06-30 | $0.04B | $-0.02B | -97.22% |
| 2014-03-31 | $0.04B | $-0.03B | -84.66% |
| 2013-12-31 | $0.04B | $-0.04B | -59.26% |
| 2013-09-30 | $0.03B | $-0.05B | -45.79% |
| 2013-06-30 | $0.03B | $-0.07B | -28.74% |
| 2013-03-31 | $0.02B | $-0.09B | -31.43% |
| 2012-12-31 | $0.02B | $-0.09B | -43.08% |
| 2012-06-30 | $0.01B | 0.00% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.209B | $0.123B |
| Performant Financial Corporation is engaged in providing technology-enabled recovery and related analytics services in the United States. The company's services help identify and recover delinquent or defaulted assets and improper payments for both government and private clients. Services offered by the company includes financial asset recovery, risk management, audit and recovery cost containment and fraud, waste and abuse marketplace. Performant provides its services on an outsourced basis. It provides services to clients in a range of different markets which includes student lending and healthcare, delinquent state taxes and federal Treasury and other receivables. Performant Financial Corporation is headquartered in Livermore, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.350B | 26.32 |
| Elevance Health (ELV) | United States | $91.117B | 11.76 |
| CVS Health (CVS) | United States | $79.102B | 9.83 |
| Cencora (COR) | United States | $56.251B | 19.57 |
| DiDi Global (DIDIY) | China | $21.979B | 33.36 |
| Natera (NTRA) | United States | $20.836B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $12.822B | 13.57 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.604B | 0.00 |
| CochLear (CHEOY) | Australia | $11.282B | 0.00 |
| Revvity (RVTY) | United States | $10.993B | 18.92 |
| ICON (ICLR) | Ireland | $10.630B | 9.88 |
| Viatris (VTRS) | United States | $10.375B | 3.56 |
| Doximity (DOCS) | United States | $9.813B | 45.70 |
| Avantor (AVTR) | United States | $9.138B | 13.28 |
| Medpace Holdings (MEDP) | United States | $8.785B | 23.33 |
| HealthEquity (HQY) | United States | $8.497B | 41.80 |
| Sonic Healthcare (SKHHY) | Australia | $8.220B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.924B | 13.57 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $4.257B | 39.40 |
| Bausch + Lomb (BLCO) | Canada | $4.156B | 24.50 |
| Sotera Health (SHC) | United States | $3.633B | 20.65 |
| Alignment Healthcare (ALHC) | United States | $3.122B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.068B | 39.90 |
| Concentras Parent (CON) | United States | $2.912B | 16.83 |
| Organon (OGN) | United States | $2.350B | 2.50 |
| Ardent Health Partners (ARDT) | United States | $2.204B | 9.40 |
| GeneDx Holdings (WGS) | United States | $1.949B | 75.07 |
| Progyny (PGNY) | United States | $1.912B | 42.08 |
| Premier (PINC) | United States | $1.904B | 14.45 |
| PACS (PACS) | United States | $1.647B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.414B | 28.29 |
| Teladoc Health (TDOC) | United States | $1.319B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.283B | 9.76 |
| Establishment Labs Holdings (ESTA) | $1.046B | 0.00 | |
| Agilon Health (AGL) | United States | $1.014B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.977B | 15.25 |
| Nutex Health (NUTX) | United States | $0.972B | 14.69 |
| AMN Healthcare Services Inc (AMN) | United States | $0.869B | 8.13 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.702B | 4.73 |
| InnovAge Holding (INNV) | United States | $0.566B | 0.00 |
| Enhabit (EHAB) | United States | $0.539B | 44.33 |
| Auna S.A (AUNA) | Luxembourg | $0.514B | 13.63 |
| Sonida Senior Living (SNDA) | United States | $0.494B | 0.00 |
| LifeMD (LFMD) | United States | $0.487B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.370B | 0.00 |
| SBC Medicals (SBC) | United States | $0.352B | 0.00 |
| Oncology Institute (TOI) | United States | $0.226B | 0.00 |
| Beauty Health (SKIN) | United States | $0.218B | 0.00 |
| DocGo (DCGO) | United States | $0.150B | 24.50 |
| Sera Prognostics (SERA) | United States | $0.087B | 0.00 |
| So-Young (SY) | China | $0.084B | 0.00 |
| OncoCyte (OCX) | United States | $0.080B | 0.00 |
| KindlyMD (KDLY) | United States | $0.078B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
| NeueHealth (NEUE) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| Biodesix (BDSX) | United States | $0.044B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.044B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.036B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |